Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT03729778
EARLY_PHASE1
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
Sponsor: VA Eastern Colorado Health Care System
View on ClinicalTrials.gov
Summary
The purpose of this study is to learn more about both HIV-1 infection and advancing age, and their association with increased risk of serious infection and impaired response to the Prevnar 13 vaccine.
Key Details
Gender
All
Age Range
21 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2017-01-18
Completion Date
2028-01-01
Last Updated
2024-07-15
Healthy Volunteers
Yes
Interventions
BIOLOGICAL
Prevnar-13
One time administration of prevnar-13 vaccine
Locations (1)
Rocky Mountain Regional VA Medical Center
Aurora, Colorado, United States